HYPERGLYCAEMIC CRISIS

HYPERGLYCAEMIC CRISIS was reported 52 times

These drug classes are most commonly taken by patients reporting HYPERGLYCAEMIC CRISIS:

# Drug Count
0 Corticosteroid [EPC] 16
1 Insulin Analog [EPC] 12
2 Tumor Necrosis Factor Blocker [EPC] 10
3 Glycopeptide Antibacterial [EPC] 9
4 Sodium-Glucose Cotransporter 2 Inhibitor [EPC] 6
5 Benzodiazepine [EPC] 5
6 Nonsteroidal Anti-inflammatory Drug [EPC] 5
7 Vitamin C [EPC] 5
8 Alkylating Drug [EPC] 4
9 Aromatase Inhibitor [EPC] 4
10 GLP-1 Receptor Agonist [EPC] 4
11 GLP-2 Analog [EPC] 4
12 Platelet Aggregation Inhibitor [EPC] 4
13 Proteasome Inhibitor [EPC] 4
14 Proton Pump Inhibitor [EPC] 4
15 Azole Antifungal [EPC] 3
16 Loop Diuretic [EPC] 3
17 Angiotensin Converting Enzyme Inhibitor [EPC] 2
18 Atypical Antipsychotic [EPC] 2
19 CD20-directed Cytolytic Antibody [EPC] 2
20 Calcineurin Inhibitor Immunosuppressant [EPC] 2
21 Dipeptidyl Peptidase 4 Inhibitor [EPC] 2
22 Erythropoiesis-stimulating Agent [EPC] 2
23 HMG-CoA Reductase Inhibitor [EPC] 2
24 PCSK9 Inhibitor [EPC] 2
25 Programmed Death Receptor-1 Blocking Antibody [EPC] 2
26 Somatostatin Analog [EPC] 2
27 Angiotensin 2 Receptor Blocker [EPC] 1
28 Calcium Channel Blocker [EPC] 1
29 Dihydropyridine Calcium Channel Blocker [EPC] 1
30 Glucose-dependent Insulinotropic Polypeptide Receptor Agonist [EPC] 1
31 Histamine-2 Receptor Antagonist [EPC] 1
32 Insulin [EPC] 1
33 Insulin-like Growth Factor-1 Receptor Inhibitor [EPC] 1
34 Janus Kinase Inhibitor [EPC] 1
35 Phosphodiesterase 3 Inhibitor [EPC] 1
36 Platinum-based Drug [EPC] 1
37 Programmed Death Ligand-1 Blocker [EPC] 1
38 Serotonin Reuptake Inhibitor [EPC] 1
39 Thalidomide Analog [EPC] 1
40 Thiazide Diuretic [EPC] 1
41 Xanthine Oxidase Inhibitor [EPC] 1